| Literature DB >> 28808955 |
Noel Conlisk1,2,3, Rachael O Forsythe4,5,6, Lyam Hollis4, Barry J Doyle4,7,8, Olivia M B McBride4,5,6, Jennifer M J Robson4,5, Chengjia Wang4,6, Calum D Gray6, Scott I K Semple4,6, Tom MacGillivray4,9, Edwin J R van Beek4,6, David E Newby4,6, Peter R Hoskins4,10.
Abstract
Inflammation detected through the uptake of ultrasmall superparamagnetic particles of iron oxide (USPIO) on magnetic resonance imaging (MRI) and finite element (FE) modelling of tissue stress both hold potential in the assessment of abdominal aortic aneurysm (AAA) rupture risk. This study aimed to examine the spatial relationship between these two biomarkers. Patients (n = 50) > 40 years with AAA maximum diameters > = 40 mm underwent USPIO-enhanced MRI and computed tomography angiogram (CTA). USPIO uptake was compared with wall stress predictions from CTA-based patient-specific FE models of each aneurysm. Elevated stress was commonly observed in areas vulnerable to rupture (e.g. posterior wall and shoulder). Only 16% of aneurysms exhibited co-localisation of elevated stress and mural USPIO enhancement. Globally, no correlation was observed between stress and other measures of USPIO uptake (i.e. mean or peak). It is suggested that cellular inflammation and stress may represent different but complimentary aspects of AAA disease progression.Entities:
Keywords: Abdominal aortic aneurysms; Finite element analysis; MRI; Patient-specific modelling; USPIO uptake
Mesh:
Substances:
Year: 2017 PMID: 28808955 PMCID: PMC5722953 DOI: 10.1007/s12265-017-9766-9
Source DB: PubMed Journal: J Cardiovasc Transl Res ISSN: 1937-5387 Impact factor: 4.132
Fig. 1Flowcharts detailing (a) patient inclusion/exclusion criteria and (b) the patient selection algorithm
Fig. 2(a) The slice with the largest mural USPIO enhancement (most diseased segment) is selected from MRI. The corresponding slice is then extracted from the CT-based FE model using relevant anatomical landmarks (e.g. Z-distance from the iliac bifurcation). The contours are then visually compared to determine if co-location occurs. Examples of aneurysms with no co-location, some periluminal co-location (which does not represent inflammation), and true co-location of elevated stress with significant mural USPIO enhancement can be seen in panels (b), (c), and (d), respectively. Note: black arrows point to approximate regions of co-location
Summary demographics of patients, per USPIO classification group, using comparisons of proportion or chi-squared test, where appropriate
| Variable | All patients ( | USPIO-negative ( | USPIO-positive ( | Difference between groups— |
|---|---|---|---|---|
| Age in years (SD) | 72.34 (6.32) | 71.96 (6.37) | 72.86 (6.37) | 0.6372 |
| Male sex (%) | 45 (90) | 25 (86) | 20 (95) | 0.383 |
| Mean AAA diameter in mm (SD) | 52.96 (6.08) | 51.34 (5.19) | 55.19 (6.62) | 0.0255 |
| Past medical history | ||||
| Family history of AAA (%) | 12 (24) | 6 (20.69) | 6 (28.57) | 0.738 |
| Coronary artery disease (%) | 16 (32) | 9 (31.03) | 7 (33.33) | 1 |
| Stroke or transient ischemic attack (%) | 3 (6) | 2 (6.90) | 1 (4.76) | 1 |
| Peripheral vascular disease (%) | 3 (6) | 3 (10.34) | 0 (0) | 0.254 |
| Cerebrovascular disease (%) | 2 (4) | 2 (6.90) | 0 (0) | 0.503 |
| Risk factors | ||||
| Current smoking habit (%) | 12 (24) | 5 (17.24) | 7 (33.33) | 0.314 |
| Previous smoking habit (%) | 32 (64) | 20 (68.97) | 12 (57.14) | 0.551 |
| Hypertension (%) | 40 (80) | 24 (82.76) | 16 (76.20) | 0.7232 |
| Hypercholesterolaemia (%) | 44 (88) | 25 (86.21) | 19 (90.48) | 1 |
| Diabetes (%) | 7 (14) | 4 (13.79) | 3 (14.29) | 1 |
| Medication | ||||
| Anti-diabetes medication (%) | 6 (12) | 5 (17.24) | 1 (4.76) | 0.38 |
| Statin therapy (%) | 2 (4) | 2 (6.90) | 0 (0) | 0.503 |
| Anti-coagulant therapy (%) | 1 (2) | 0 (0) | 1 (4.76) | 0.42 |
Fig. 3Global comparisons (n = 50) of aneurysm diameter, peak stress predicted by finite element analysis, and % ∆T2* USPIO, using data from the entire aneurysm. There are no significant correlations between any of the measured parameters
Fig. 4Comparisons of diameter, peak stress, and % ∆T2* USPIO uptake per group; USPIO-negative (n = 29) vs USPIO-positive (n = 21), using data from the entire aneurysm. No significant correlations demonstrated
Fig. 5Mural USPIO enhancement analysis. Correlation between peak stress (derived from the entire aneurysm) with mean and peak USPIO uptake on the most diseased segment (n = 21). No significant correlations identified
Fig. 6Mural USPIO enhancement analysis. Correlation between aneurysm diameter with mean and peak USPIO uptake in the identified areas of significant mural USPIO enhancement on the most diseased segment (n = 21)